Herbas VPB

Print
EN | LT
LT - Rekombinantinė žmogaus rūgštinė alfa-glukozidazė
EN - RECOMBINANT HUMAN ACID ALPHA-GLUCOSIDASE

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/43 (2006.01)
A61P 21/00 (2006.01)
A61P 25/00 (2006.01)
A61P 43/00 (2006.01)
A61K 38/47 (2006.01)
European patent
(11) Number of the document 3624831
(13) Kind of document T
(96) European patent application number 18802722.1
Date of filing the European patent application 2018-05-15
(97) Date of publication of the European application 2020-03-25
(45) Date of publication and mention of the grant of the patent 2023-03-29
(46) Date of publication of the claims translation 2023-07-10
PCT application
(86) Number PCT/US2018/032815
Date 2018-05-15
PCT application publication
(87) Number WO 2018/213340
Date 2018-11-22
Priority applications
(30) Number Date Country code
201762506561 P 2017-05-15 US
201762506574 P 2017-05-15 US
201762506569 P 2017-05-15 US
201762529300 P 2017-07-06 US
201762564083 P 2017-09-27 US
201762567334 P 2017-10-03 US
201862618021 P 2018-01-16 US
201862624638 P 2018-01-31 US
201862660758 P 2018-04-20 US
Inventors
(72)
DO, Hung , US
GOTSCHALL, Russell , US
KHANNA, Richie , US
LUN, Yi , US
CHAR, Hing , US
TESLER, Sergey , US
SUNDERLAND, Wendy , US
DILONÉ, Enrique , US
Grantee
(73) Amicus Therapeutics, Inc. , 3675 Market Street, Philadelphia, PA 19104, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Rekombinantinė žmogaus rūgštinė alfa-glukozidazė
  RECOMBINANT HUMAN ACID ALPHA-GLUCOSIDASE
Last renewal fee
Payment date Validity (years) Amount
2025-03-21 8 185.00 EUR
Next renewal fee
2026-05-15